The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.09%1.58M | 0.88%852.65K | -10.16%453.4K | -0.13%3.37M | -20.35%471.96K | 10.15%1.54M | -7.82%845.24K | 9.94%504.69K | 36.89%3.37M | 27.27%592.54K |
Operating revenue | 2.09%1.58M | 0.88%852.65K | -10.16%453.4K | -0.13%3.37M | -20.35%471.96K | 10.15%1.54M | -7.82%845.24K | 9.94%504.69K | 36.89%3.37M | 27.27%592.54K |
Cost of revenue | 1.64%82.04K | 2.94%63.46K | 10.88%49.28K | 14.44%224.05K | 7.53%37.24K | 21.17%80.72K | -7.11%61.65K | 57.80%44.45K | 18.63%195.78K | 292.02%34.63K |
Gross profit | 2.11%1.49M | 0.71%789.19K | -12.20%404.11K | -1.03%3.14M | -22.08%434.72K | 9.60%1.46M | -7.87%783.59K | 6.81%460.24K | 38.20%3.18M | 22.15%557.91K |
Operating expense | -8.19%1.15M | 5.43%1.12M | 0.72%895.11K | -3.74%4.18M | -6.33%981.43K | 0.98%1.25M | 0.15%1.06M | -11.03%888.68K | 20.61%4.35M | 9.37%1.05M |
Selling and administrative expenses | -0.65%799.88K | 8.78%760.06K | 11.05%587.35K | -4.72%2.67M | -9.34%632.72K | -4.03%805.12K | 3.30%698.73K | -11.93%528.89K | 11.95%2.8M | 16.25%697.9K |
-Selling and marketing expense | 57.79%44.91K | -30.85%10.34K | 151.09%42.68K | -38.42%83.36K | -30.98%22.94K | -40.76%28.46K | -56.38%14.96K | -52.82%17K | -22.90%135.38K | -59.59%33.24K |
-General and administrative expense | -2.79%754.97K | 9.65%749.72K | 6.40%544.67K | -3.01%2.58M | -8.26%609.78K | -1.80%776.66K | 6.49%683.77K | -9.32%511.9K | 14.59%2.66M | 28.29%664.67K |
Depreciation amortization depletion | -12.70%163.57K | -9.90%168.84K | -8.82%169.76K | -5.03%746.94K | -8.37%185.99K | -6.00%187.37K | -2.99%187.4K | -2.55%186.19K | 58.27%786.53K | -7.37%202.99K |
-Depreciation and amortization | -12.70%163.57K | -9.90%168.84K | -8.82%169.76K | -5.03%746.94K | -8.37%185.99K | -6.00%187.37K | -2.99%187.4K | -2.55%186.19K | 58.27%786.53K | -7.37%202.99K |
Other taxes | 9.84%17.62K | 34.28%15.1K | 24.65%13.76K | 15.79%54.36K | 24.11%16.04K | 24.11%16.04K | 6.57%11.24K | 4.63%11.04K | 11.24%46.95K | 22.48%12.92K |
Other operating expenses | -30.74%169.55K | 6.74%173.85K | -23.57%124.24K | 0.21%716.9K | 9.54%146.68K | 28.83%244.79K | -8.80%162.87K | -17.34%162.56K | 26.45%715.39K | 4.66%133.91K |
Operating profit | 63.47%344.26K | -18.80%-328.66K | -14.60%-491K | 11.11%-1.04M | -11.62%-546.71K | 122.80%210.59K | -32.93%-276.64K | 24.56%-428.44K | 10.34%-1.17M | 2.28%-489.82K |
Net non-operating interest income (expenses) | 6.08%-289.19K | 18.19%-243.45K | -13.65%-303.86K | -5.21%-1.18M | 42.43%-306.37K | -42.78%-307.92K | -54.20%-297.57K | -48.49%-267.37K | -103.46%-1.12M | -205.24%-532.13K |
Non-operating interest expense | -2.23%289.19K | -18.19%243.45K | 14.94%303.86K | 4.43%1.16M | -42.43%306.37K | 37.15%295.78K | 59.22%297.57K | 46.82%264.37K | 115.74%1.11M | 205.24%532.13K |
Total other finance cost | ---- | ---- | ---- | 148.81%15.14K | --0 | --12.14K | ---- | --3K | -82.18%6.09K | --0 |
Other net income (expenses) | -79.84%13.06K | -20.96%15.08K | 141.20%12.99K | 301.31%147.86K | 1,018.28%95.56K | 122.27%64.77K | 3,665.23%19.07K | -10,207.52%-31.54K | 102.29%36.84K | 100.52%8.55K |
Gain on sale of security | -223.38%-1.55K | 43.54%-297 | 72.71%-188 | 34.25%-1.85K | 86.08%-157 | -63.48%-479 | 25.18%-526 | 0.29%-689 | -183.48%-2.82K | -76.53%-1.13K |
Special income (charges) | --0 | --0 | 100.38%156 | 460.13%91.44K | --81.29K | 212.48%51.01K | --0 | ---40.86K | 100.98%16.33K | --0 |
-Less:Other special charges | ---- | ---- | ---- | -564.23%-108.44K | ---81.29K | -316.58%-68.01K | ---- | --40.86K | ---16.33K | --0 |
-Gain on sale of property,plant,equipment | --0 | --0 | --156 | ---16.99K | --0 | ---16.99K | --0 | --0 | --0 | --0 |
Other non-operating income (expenses) | 2.61%14.6K | -21.56%15.37K | 30.17%13.03K | 149.71%58.27K | 49.15%14.43K | 8.58%14.23K | 11,566.67%19.6K | 2,499.22%10.01K | -57.05%23.33K | -63.06%9.67K |
Income before tax | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 34.91%-2.26M | 56.20%-1.01M |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 33.08%-2.26M | 54.32%-1.01M |
Net income continuous operations | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 33.08%-2.26M | 54.32%-1.01M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 33.08%-2.26M | 54.32%-1.01M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 33.08%-2.26M | 54.32%-1.01M |
Diluted earnings per share | 218.33%0.0028 | 50.00%-0.08 | 0.00%-0.04 | 25.00%-0.12 | 62.50%-0.03 | 64.60%-0.0023 | -300.00%-0.16 | 0.00%-0.04 | 42.86%-0.16 | 49.58%-0.08 |
Basic earnings per share | 218.33%0.0028 | 50.00%-0.08 | 0.00%-0.04 | 25.00%-0.12 | 62.50%-0.03 | 64.60%-0.0023 | -300.00%-0.16 | 0.00%-0.04 | 42.86%-0.16 | 49.58%-0.08 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.